Skip to main content

Table 6 Comparison of laboratory data between survivals and deaths

From: Prognostic factors and monomicrobial necrotizing fasciitis: gram-positive versus gram-negative pathogens

 

Survival n = 39

non-survival n = 7

p-value

Total WBC

   

   Leukocytosis(> 12,000/ul)

27 (69.2)

4 (57.1)

0.667

   Leukopenia(< 4,000/ul)

2 (5.1)

2 (28.6)

0.104

   Leukocytosis or leukopenia

29 (74.3)

6 (85.7)

0.667

Differential count

   

   Band formation

35 (89.7)

7 (100)

1.000

   neutrophilia(> 7,500/ul)

29 (74.3)

4 (57.1)

0.385

   lymphocytopenia(< 1,000/ul)

16 (41.0)

5 (71.4)

0.220

Thrombocytopenia(< 150,000/ul)

7 (17.9)

5 (71.4)

0.009

Hemoglobin(g/dL)

12.6 (7.7, 15.8)

12.4 (10.0, 14.7)

0.866

C-reactive protein (mg/dL)

135 (50, 373)

97 (63, 227)

0.915

Glucose (mg/dL)

194.9 (90, 842)

152 (105, 264)

0.667

Sodium (meq/L)

134.6(124, 141)

134.4 (127, 140)

0.988

Creatinine > 1.6 mg/dL

5 (12.8)

4 (57.1)*

0.020

Hypoalbuminemia(< 3 g/dL)

22 (56.4)

7 (100)*

0.036

LRINEC score

5.1 (0, 12)

3.7 (0, 70

0.217

APACHE II

16.9 (2, 34)

21.3 (17, 27)

0.090

ICU stay (patient numbers)

23 (59.0)

7 (100)

0.078

post-OP ventilator (patient numbers)

21 (53.8)

7 (100)*

0.032

ICU stay (day)

2.5 (0, 16)

10.3 (7, 14)*

< 0.001

Hospital stay(day)

36 (13, 87)

34.6 (14, 79)

0.635

  1. Data are presented as median (min, max) or frequency (%)
  2. APACHE, acute physiological, age, and chronic health evaluation
  3. Chronic liver dysfunction: liver cirrhosis, viral hepatitis(HBV, or HCV)
  4. *: The difference is significant (p < 0.05)